Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts.
about
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplantsAcute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?Bioactive natural products with anti-herpes simplex virus properties.Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.Susceptibilities of human cytomegalovirus clinical isolates and other herpesviruses to new acetylated, tetrahalogenated benzimidazole D-ribonucleosidesOcular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS.Solubility and dissolution enhancement strategies: current understanding and recent trends.Treatment of Cytomegalovirus Infection or Disease in Solid Organ Transplant Recipients with Valganciclovir
P2860
Q35558815-A7DC6B37-B96D-416C-9F1B-C0807B43211FQ36748051-99AE1D04-F463-4D65-B888-1222FDFB3120Q38523078-271AACE5-CFAB-499E-8BE9-24E1756EFD0AQ42022232-E2BAD6F3-62B6-4F2A-A96A-6C30B1C02462Q42687324-3408C40B-C817-4362-B382-E8D80B040CD7Q44377380-CA7DE1BA-54DE-4943-8D99-583390782692Q51020710-E813EF5F-E811-4F07-B819-E516C972F1E8Q57763738-76978952-F77F-4028-9D0D-8AF0C60C9B7B
P2860
Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@ast
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@en
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@nl
type
label
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@ast
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@en
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@nl
prefLabel
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@ast
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@en
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@nl
P2860
P1476
Oral valganciclovir: a new opt ...... se in immunocompromised hosts.
@en
P2093
P2860
P304
P356
10.1517/13543784.10.9.1745
P407
P577
2001-09-01T00:00:00Z